Health Canada has opened a public consultation regarding the potential regulatory pathway for products containing cannabidiol (CBD). This consultation will run from March 7, 2025, to June 5, 2025, inviting stakeholders to provide feedback on the proposed amendments to how CBD is classified and sold in Canada. The focus is on creating a framework that enables access to CBD health products without the need for prescription oversight, aiming to improve the current regulations while maintaining public health and safety standards. Interested parties can review the discussion paper and submit input through the Health Canada consultation platform.
For more details, check the consultation document here.
